Drug Shortage Report for ENERZAIR BREEZHALER
| Report ID | 228307 |
| Drug Identification Number | 02501244 |
| Brand name | ENERZAIR BREEZHALER |
| Common or Proper name | ENERZAIR 150/50/160MCG 3X10 +1D |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | MOMETASONE FUROATE GLYCOPYRRONIUM INDACATEROL |
| Strength(s) | 160MCG 50MCG 150MCG |
| Dosage form(s) | CAPSULE |
| Route of administration | INHALATION |
| Packaging size | 3X10 +1d |
| ATC code | R03AL |
| ATC description | |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2024-05-13 |
| Actual start date | 2024-05-13 |
| Estimated end date | 2024-05-23 |
| Actual end date | 2024-05-21 |
| Shortage status | Resolved |
| Updated date | 2024-05-22 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2024-05-22 | French | Compare |
| v6 | 2024-05-22 | English | Compare |
| v5 | 2024-05-17 | French | Compare |
| v4 | 2024-05-17 | English | Compare |
| v3 | 2024-05-17 | French | Compare |
| v2 | 2024-05-17 | English | Compare |
| v1 | 2024-05-17 | English | Compare |
Showing 1 to 7 of 7